002437 譽衡藥業
按盤價 
4.390 +0.250 (+6.039%)
4.390 +0.250 (+6.039%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.674 | 17.760 | 12.886 | 7.308 | -16.527 |
| 總資產報酬率 ROA (%) | 4.971 | 12.648 | 7.788 | 3.330 | -6.644 |
| 投入資產回報率 ROIC (%) | 6.302 | 16.912 | 10.548 | 4.311 | -8.525 | 邊際利潤分析 |
| 銷售毛利率 (%) | 46.359 | 45.347 | 53.460 | 58.389 | 56.925 |
| 營業利潤率 (%) | 18.224 | 18.961 | 11.671 | 6.666 | -8.690 |
| 息稅前利潤/營業總收入 (%) | 18.373 | 19.166 | 11.579 | 7.924 | -7.173 |
| 淨利潤/營業總收入 (%) | 16.120 | 17.905 | 9.937 | 4.901 | -9.315 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 83.383 | 55.967 | 78.232 | 77.354 | -22.987 |
| 價值變動淨收益/利潤總額(%) | 2.787 | 34.789 | -3.077 | -23.404 | 99.959 |
| 營業外收支淨額/利潤總額(%) | -0.077 | 1.149 | -0.409 | 0.979 | -0.151 | 償債能力分析 |
| 流動比率 (X) | 1.884 | 1.653 | 1.066 | 0.818 | 0.777 |
| 速動比率 (X) | 1.627 | 1.395 | 0.837 | 0.683 | 0.686 |
| 資產負債率 (%) | 23.664 | 26.319 | 30.167 | 45.749 | 58.187 |
| 帶息債務/全部投入資本 (%) | 4.005 | 5.073 | 1.620 | 29.485 | 47.661 |
| 股東權益/帶息債務 (%) | 2,372.228 | 1,849.429 | 5,981.618 | 234.766 | 107.551 |
| 股東權益/負債合計 (%) | 320.086 | 278.020 | 228.885 | 115.223 | 68.810 |
| 利息保障倍數 (X) | 112.688 | -1,201.936 | -264.700 | 6.646 | -4.769 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 22.060 | 21.199 | 24.346 | 29.737 | 26.273 |
| 存貨周轉天數 (天) | 66.190 | 60.851 | 60.111 | 66.682 | 76.131 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/08/2026 13:05 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
